A new strategy to strengthen the body’s natural immune defenses against cancer is showing early promise, particularly for patients with limited treatment options.

AT-108 induces powerful, personalized anti-cancer responses by forcing tumor cells to present their antigens to the immune ...

For something so small, the thymus has had an oddly quiet life in medicine. It sits behind the sternum and helps train T ...

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, is advancing partnering ...

A new study found zero relapses among patients given a new treatment regime, with far better results than would be expected ...

In this video, Lukas Delasos, DO, discusses highlights from this year’s International Association for the Study of Lung ...

Fecal microbiota transplantation is an emerging strategy for modulating the gut microbiome to influence immunotherapy ...

A new grant from the American Cancer Society (ACS) will fund research into a new strategy for targeting glioblastoma at MUSC ...

A new clinical trial at UH Seidman Cancer Center will investigate whether a specific strain of Clostridium butyricum can ...

As colorectal cancer rates rise among young people, most patients with advanced disease still only have one treatment option: ...

Immunotherapy is a cancer treatment that harnesses the body’s immune system to fight cancer. It helps the immune system recognize and attack cancer cells, which can sometimes be hidden from the body’s ...

Immunotherapy has transformed cancer treatment by helping the body’s immune system recognize and attack cancer cells more ...